Search

 
 
 
Lilly Licenses Sigilon's Cell Encapsulation Tech for Diabetes Therapy

LILLY LICENSES SIGILON'S CELL ENCAPSULATION TECH FOR DIABETES THERAPY

A day after Pfizer decided to step back from the development of a universal cell therapy for cancer, Eli Lilly is jumping in, this...

 
 
 
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More

BIO ROUNDUP: BIOTECH IPOS, MIGRAINE PROGRESS, TAKEDA WOOS SHIRE & MORE

If the recent IPO activity seems to be on overdrive, it's not your imagination. The number of companies filing to go public in the...

 
 
 
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More

BIO ROUNDUP: DIY BIOHACKING, PCSK9 DATA, SOLID SETBACK & MORE

Drug prices are top of mind for many patients. Some of them have to cut back on basic needs just to pay for treatments that seem to...

 
 
 

U.K. COULD SEEK RESTITUTION FROM PFIZER IF LEGAL APPEAL FAILS

Pfizer is fighting to preserve Lyrica's use as the preferred physician's treatment for nerve pain in the U.K.

MOLECULAR ASSEMBLIES EXPANDS LEADERSHIP TEAM WITH APPOINTMENT OF VICE PRESIDENT OF CHEMISTRY AND BIOCHEMISTRY

Former Pfizer and Agouron Pharmaceuticals executive Kim Albizati joins company SAN DIEGO, Feb. 26, 2018 /PRNewswire/ - Molecular Assemblies,...

 
 
 
Biggest US drugmaker puts up huge 4Q profit thanks to tax overhaul

BIGGEST US DRUGMAKER PUTS UP HUGE 4Q PROFIT THANKS TO TAX OVERHAUL

Pfizer is also paying a hefty $15 billion bill to the Treasury over eight years, covering taxes on profits held overseas that it plans...

 
 
 
Pfizer, riding tax changes, puts up huge 4Q profit

PFIZER, RIDING TAX CHANGES, PUTS UP HUGE 4Q PROFIT

Pfizer's fourth-quarter profit soared to $12.27 billion thanks to a huge tax benefit related to the U.S. tax system overhaul.

Pfizer beats Street 4Q forecasts

PFIZER BEATS STREET 4Q FORECASTS

NEW YORK - Pfizer is reporting fourth-quarter net income of $12.27 billion, which is better than anticipated. The New York company's...

 
 
 
 
 
 
Every New FDA Drug Approval in 2017

EVERY NEW FDA DRUG APPROVAL IN 2017

2017 was a busy year for the FDA. With 46 approvals, the year far outpaced the 22 approvals in 2016. We've already shown you every...

Pfizer ends research for new Alzheimer's Parkinson's drugs

PFIZER ENDS RESEARCH FOR NEW ALZHEIMER'S PARKINSON'S DRUGS

Despite investing heavily in trying to cure both diseases, the US drugs giant has now decided to redistribute funding to other areas...

 
 
 

PFIZER AXING NEUROSCIENCE JOBS, BUT SEEKS NEW VC FUND

Big Pharma Pfizer, on the eve of J.P. Morgan, the biggest biopharma dating event on the year, is to cut around 300 jobs and a number...

VP, EARLY ONCOLOGY CLINICAL DEVELOPMENT - PFIZER - LA JOLLA, CA

Collaboration with Pfizer External Research, Development, and Innovation , WRD and ORD leadership to identify new preclinical or pre-PoC...